Anemia – A Finding, Not Yet a Diagnosis (Muncie)

Upon completion of this session, using the Cochrane Abstract Database and AAFP Guidelines, the participant should be able to: ^{EBM,GL, COMP}

1. Distinguish the etiologies for the common anemias.
2. Construct the diagnostic evaluation to determine the etiology of each anemia.
3. Develop the therapeutic options for each identified anemia.
4. Formulate the appropriate follow-up evaluations for assessing the treatment efficacy.

Thyroid Dysfunction: Evaluation and Treatment (Muncie)

Upon completion of this session, using the American Thyroid Association Guidelines and the Cochrane Abstract Database, the participant should be able to: ^{EBM,GL, COMP}

1. Integrate the serum tests for thyroid function.
2. Interpret thyroid tests results that occur in clinical settings.
3. Recommend the appropriate follow-up testing of abnormal thyroid tests and the frequency of these evaluations.
4. Appraise the need to treat subclinical hypothyroidism or subclinical hyperthyroidism.

Contraception (Nelson)

Attendees of this presentation will be able to:

1. Discuss the contribution contraception makes to women’s health.
2. Describe barriers to successful contraceptive use.
3. Counsel women on the safety and efficacy of each of the current methods in typical use.
4. Outline approach to implement the US MEC and Selected Contraceptive Practices in practice.

Diagnosis and Treatment of Heavy Menstrual Bleeding (Nelson)

Attendees of this presentation will be able to:

1. Utilize FIGO definitions for normal and abnormal bleeding and the PALM-COIEN classification system.
2. Explain the evolution of menstruation in humans and defects that could disrupt controls of blood loss.
3. Describe the work-up of a woman with acute or chronic HMB personalized to her risk factors and clinical presentation.

PCOS (Nelson)

Attendees of this presentation will be able to:

1. Discuss the Rotterdam diagnostic criteria and differential diagnoses for PCOS.
2. Tailor therapies to meet the individual needs of women with PCOS.
3. Outline remaining controversies and potential future changes

Perimenopause and menopause (Nelson)

Attendees of this presentation will be able to:

1. Counsel women about the endocrinologic changes that occur during perimenopause and menopause.
2. Identify any differences seen in different ethnic groups – both physiologically and culturally.
3. Describe how those changes can affect current symptomatology and long-term health.
4. Outline therapeutic options from lifestyle changes to over-the-counter medications to prescription drugs (nonhormonal and hormonal) for each of the manifestations of perimenopause and menopause

Breast cancer screening and prevention (Nelson)

Attendees of this presentation will be able to:

1. Identify facts that increase a woman’s risk for developing breast cancer.
2. List methods for screening women for early breast cancer and explain the implications of early or more frequent breast cancer screening tests.
3. Counsel women on preventive measures available to reduce the risk of breast cancer among those with moderate to high risk estimates.

GYN cancer screening and prevention (Nelson)

Attendees of this presentation will be able to:

1. Identify risk factors and clinical presentations for each of those cancers
2. Suggest prevention strategies to reduce risks of each of those cancers.

Diagnosis and management of Type 2 Diabetes (Muncie)

Attendees of this presentation using the American Diabetes Association, the European Association for the Study of Diabetes Guidelines and the Cochrane Abstract Database and current literature, should be able to:

1. Delineate a treatment plan for preventing type 2 diabetes.
2. Compare the options for diagnosing type 2 diabetes
3. Evaluate the therapeutic goals in treating type 2
4. Diabetes and their impact on morbidity and mortality.
5. Recommend the approach for choosing an oral   hypoglycemic agent to treat type 2 diabetes.
6. Compare the cardiovascular effects of the current oral treatment options for type 2 diabetes
7. Specify the clinical situations that would require the use of insulin to treat type 2 diabetes and the probable dosage form and average amounts required for control of A1c.
8. Develop the therapeutic options for preventing diabetic complications.

Treatment of depression and anxiety in primary care (Muncie)

Attendees of this presentation using the APA Guidelines, the Cochrane Abstract Database and current literature,  should be able to:

1. Describe and compare the diagnostic instruments for diagnosing depression and GAD
2. Apply the initial treatment algorithm for endogenous depression.
3. Describe the common side effects associated with pharmacologic treatment of endogenous depression.
4. Compare and contrast the diagnostic criteria for GAD.
5. Compare the side effect profiles for the current 6. armacologic treatment of GAD
6. Employ the current literature for when to refer a patient with depression or GAD to a psychiatrist

Suicide and Violence (Zun)

Attendees of this presentation should be able to:

1. Analyze the process to evaluate patients for risk of suicide
2. Determine the difference between suicide screening and suicide risk assessment
3. Formulate the next steps after risk assessment, including discharge
4. Employ strategies to reduce incidence of violence in healthcare institutions

Substance abuse (Zun)

Attendees of this presentation should be able to:

1. Evaluate the risk factors leading to substance abuse and addiction
2. Utilize several screening tools for substance abuse and  addiction
3. Review the medical and psychiatric consequences and comorbidities of substance abuse
4. Utilize biological and psychosocial treatments for substance abuse

Diagnosis and treatment of recurrent headaches – migraine, tension, cluster (Muncie)

Attendees of this presentation using the International Headache Society and U.S. Headache Consortium Guidelines and the National Guideline Clearinghouse, the evidence-based reports from Clinical Evidence and current literature,  should be able to:

1. Construct the approach for evaluating a patient with recurrent headaches.
2. Compare and contrast the initial therapies for migraine headaches
3. Assess the advantages of supportive therapy and lifestyle changes in treating migraine headaches compared to pharmacologic therapy.
4. Appraise the pharmacologic options for treating the acute pain of a migraine headache.
5. Recommend a prophylactic therapy regimen for patients with recurrent migraine headaches
6. Differentiate the symptoms associated with migraine, tension and cluster headaches.

Treatment of Sexually Transmitted Infections (Muncie)

Upon completion of this session, using the CDC Guidelines and the Cochrane Abstract Database, the participant should be able to: ^{EBM,GL, COMP}

1. Determine the appropriate diagnostic testing for complaints suggestive of a sexually transmitted infection.
2. Select the therapy for the commonly encountered sexually transmitted infections.
3. Formulate the follow-up testing and evaluations for sexually transmitted infections.
4. Recommend the therapeutic options for preventing herpes simplex infections.

Management of Benign Breast Disease (Muncie)

Upon completion of this session, using the American Cancer Society Guidelines and the Cochrane Abstract Database, the participant should be able to: ^{EBM,GL, COMP}

1. Differentiate the signs and symptoms associated with benign breast disease.
2. Formulate an evaluation for breast pain (mastalgia), breast lumps, and nipple discharge.
3. Specify the treatment options for breast pain, nipple discharge and breast infections.
4. Distinguish the symptoms and physical findings associated with rare benign breast disease conditions.

Provider Wellness (Zun)

Attendees of this presentation should be able to:

1. Identify and define stress and how it affects us
2. Differentiate, diagnose and treat  PTSD and Burnout
3. Understand and deal with the affects of COVID on physician wellness

Dealing with Difficult Patients (Zun)

Attendees of this presentation should be able to:

1. Describe why some patients and family members might be difficult to deal with difficult people
2. Recognize and respond to difficult individuals identify various types of difficult people
3. Implement techniques to deal with difficult patients and family members
4. Evaluate how medical and psychiatric illness affects difficult people

Osteoporosis: Treatment and Prevention (Muncie)

Upon completion of this session, using the USPSTF, NOF Guidelines and the Cochrane Abstract Database, the participant should be able to: ^{EBM,GL, COMP}

1. Debate the importance of the risk factors for an osteoporosis fracture.
2. Employ the diagnostic testing for patients at risk with osteoporosis.
3. Select the therapeutic medication to treat osteoporosis based upon the indications and side effects.
4. Assess the therapeutic role of repeating the DXA scan in patients treated for osteoporosis.

Screening for disease prevention and immunizations in primary care (Muncie)

Attendees of this presentation using the USPSTF and Cochrane Abstract Database and current literature,  should be able to:

1. Apply the evidence-based recommendations for preventive screening tests for adults.
2. Determine the immunizations required for adults.
3. Appraise the side effects of adult immunizations.
4. Select the contraindications for each adult immunization and their alternative therapy.
5. Plan when screening tests can be discontinued in adults.

Evaluation and Treatment of Ischemic Heart Disease in Women (Muncie)

Upon completion of this session, using the American College of Cardiology, the American Heart Association, the USPSTF Guidelines and the Cochrane Abstract Database, the participant should be able to: ^{EBM,GL, COMP}

1. Differentiate the symptoms that women with coronary artery disease (CAD) exhibit in contrast to those experienced by men.
2. Recommend the evidence-based interventions to prevent CAD in women.
3. Formulate the recommendations to treat the risk factors for CAD in women.
4. Specify the treatment required for women with proven CAD.